Fred’s Completes Sale of Specialty Pharmacy Unit

We represented Fred’s, Inc. (Nasdaq: FRED) in its sale of the assets of EntrustRx, a specialty pharmacy unit, to CVS Health Corporation for $40 million and the subsequent closing of the pharmacy operations. This transaction was an important step in Fred’s plans to monetize non-core assets as part of its broader turnaround efforts.

Fred’s, Inc., headquartered in Memphis, Tennessee, operates approximately 600 general merchandise and pharmacy stores, including 12 franchised locations.

You Also May Be Interested In:

  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019.  Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation's Naval Systems Business...
    Client Type: Private Company
  • Represented C-III Capital Partners in its sale of California-based tech company Real Capital Markets (RCM) to LightBox

    We represented C-III Capital Partners, a fully-diversified asset management and commercial real estate services company, in its sale of California-based...
    Client Type: Private Company
  • We represented SERVPRO in its recapitalization transaction, in partnership with Blackstone, one of the world’s leading investment firms. Blackstone is...
    Client Type: Private Company